176 related articles for article (PubMed ID: 37176606)
1. Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study.
Parra RS; Chebli JMF; Chebli LA; Lima Junior SF; Lins Neto MA; Medeiros TR; Faria FM; Feitosa MR; Nigro CMC; Féres O
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176606
[TBL] [Abstract][Full Text] [Related]
2. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.
Buck M; Dumic I; McDermott W; Nordstrom C; Dawan S; Virata A; Martin S; Hudson A; Milovanovic T; Nordin T
BMC Gastroenterol; 2020 Jul; 20(1):240. PubMed ID: 32727390
[TBL] [Abstract][Full Text] [Related]
3. Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease.
Rocha TB; Garate ALSV; Beraldo RF; Lanças SHS; Leite FV; Quera R; Barros JR; Baima JP; Saad-Hossne R; Sassaki LY
Case Rep Gastroenterol; 2021; 15(3):825-831. PubMed ID: 34720830
[TBL] [Abstract][Full Text] [Related]
4. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers.
Rasmussen C; Abitbol V; El Karoui K; Bourrier A; Paule R; Vuitton L; Maurier F; Laharie D; Fuméry M; Agard C; Collins M; Nancey S; Rafat C; Kervegant AG; Queyrel-Moranne V; Moulis G; Pigneur B; Régent A; Gay C; Morbieu C; Durel CA; Ducloux D; Aubin F; Voicu M; Joher N; Szwebel T; Martinez-Vinson C; Koch S; Guillevin L; Peyrin-Biroulet L; Terrier B
Rheumatology (Oxford); 2022 May; 61(5):1957-1965. PubMed ID: 34427590
[TBL] [Abstract][Full Text] [Related]
5. Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn's Disease.
Xu LC; Grandhe S; Marsano JG
Case Rep Gastroenterol; 2023; 17(1):143-147. PubMed ID: 36874386
[TBL] [Abstract][Full Text] [Related]
6. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
Mohan N; Edwards ET; Cupps TR; Slifman N; Lee JH; Siegel JN; Braun MM
J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
[TBL] [Abstract][Full Text] [Related]
7. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
8. Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature.
Pantic I; Jevtic D; Nordstrom CW; Madrid C; Milovanovic T; Dumic I
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160187
[TBL] [Abstract][Full Text] [Related]
9. Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India.
Sahu P; Vuyyuru SK; Kante B; Agarwal A; Sharma R; Das P; Panwar R; Jain S; Bopanna S; Makharia G; Kedia S; Ahuja V
Indian J Gastroenterol; 2020 Aug; 39(4):388-397. PubMed ID: 32880844
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
11. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.
Afzali A; Wheat CL; Hu JK; Olerud JE; Lee SD
J Crohns Colitis; 2014 Jun; 8(6):480-8. PubMed ID: 24268978
[TBL] [Abstract][Full Text] [Related]
12. Leukocytoclastic Vasculitis in a Patient With Crohn Disease: A Case Report.
Bugada MD; Emani VK
J Investig Med High Impact Case Rep; 2023; 11():23247096231181865. PubMed ID: 37357841
[TBL] [Abstract][Full Text] [Related]
13. Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.
Song JH; Kang EA; Park SK; Hong SN; Kim YS; Bang KB; Kim KO; Lee HS; Kang SB; Shin SY; Song EM; Im JP; Choi CH;
Gut Liver; 2021 Sep; 15(5):752-762. PubMed ID: 33767028
[TBL] [Abstract][Full Text] [Related]
14. Leukocytoclastic Vasculitis as the Presenting Symptom of Crohn's Disease in an Adolescent.
Ford V; Mooney C; Shah M; Jenkins E
J Investig Med High Impact Case Rep; 2020; 8():2324709620947608. PubMed ID: 32762386
[TBL] [Abstract][Full Text] [Related]
15. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota.
Arora A; Wetter DA; Gonzalez-Santiago TM; Davis MD; Lohse CM
Mayo Clin Proc; 2014 Nov; 89(11):1515-24. PubMed ID: 24981218
[TBL] [Abstract][Full Text] [Related]
16. Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients.
Bouiller K; Audia S; Devilliers H; Collet E; Aubriot MH; Leguy-Seguin V; Berthier S; Bonniaud P; Chavanet P; Besancenot JF; Vabres P; Martin L; Samson M; Bonnotte B
Medicine (Baltimore); 2016 Jul; 95(28):e4238. PubMed ID: 27428231
[TBL] [Abstract][Full Text] [Related]
17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
18. An Unusual Case of Apixaban-Induced Small Vessel Vasculitis: Leukocytoclastic Vasculitis.
Adebayo AY; Ali A; Goswami RM; Abimbolu O; Nayab K; Onyemarim H
Cureus; 2024 Feb; 16(2):e55040. PubMed ID: 38550439
[TBL] [Abstract][Full Text] [Related]
19. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
[TBL] [Abstract][Full Text] [Related]
20. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
Absah I; Faubion WA
Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
